Your search "COVID" returned 55 publications
Publications 41-50 of 55
-
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
Antonelli, M., Penfold, R., Merino, J., Sudre, C., Molteni, E., Berry, S., et al.
The Lancet. Infectious Diseases
-
SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion
Ferreira, I., Kemp, S., Datir, R., Saito, A., Meng, B., Rakshit, P., et al.
The Journal of Infectious Diseases
-
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Collier, D., Ferreira, I., Kotagiri, P., Datir, R., Lim, E., Touizer, E., et al.
Nature
-
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease
Bergamaschi, L., Mescia, F., Turner, L., Hanson, A., Kotagiri, P., Dunmore, B., et al.
Immunity
-
Single-cell multi-omics analysis of the immune response in COVID-19
Stephenson, E., Reynolds, G., Botting, R., Calero-Nieto, F., Morgan, M., Tuong, Z., et al.
Nature Medicine
-
Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection
Jones, N., Rivett, L., Seaman, S., Samworth, R., Warne, B., Workman, C., et al.
eLife
-
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Collier, D., De Marco, A., Ferreira, I., Meng, B., Datir, R., Walls, A., et al.
Nature
-
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
Collier, D., De Marco, A., Ferreira, I., Meng, B., Datir, R., Walls, A., et al.
medRxiv: The Preprint Server for Health Sciences
-
SARS-CoV-2 evolution during treatment of chronic infection
Kemp, S., Collier, D., Datir, R., Ferreira, I., Gayed, S., Jahun, A., et al.
Nature
-
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
Buckland, M., Galloway, J., Fhogartaigh, C., Meredith, L., Provine, N., Bloor, S., et al.
Nature Communications